A novel mechanism for C1GALT1 in the regulation of gastric cancer progression
Open Access
- 26 August 2021
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 11 (1) , 1-15
Abstract
Background: Gastric cancer (GC) is a highly aggressive and lethal disease around the world. High expression of core 1 β 1, 3-galactosyltransferase 1 (C1GALT1), the primary enzyme responsible for protein O-glycosylation, plays a critical role in gastric carcinogenesis. However, proteins that can be O-glycosylated by C1GALT1 in GC have not been completely elucidated. Also, the mechanism leading to its upregulation in GC is currently unknown. Results: Using public databases and our patient samples, we confirmed that C1GALT1 expression was upregulated at both the mRNA and protein levels in GC tissues. Elevated expression of C1GALT1 protein was closely associated with advanced TNM stage, lymph node metastasis, tumor recurrence, and poor overall survival. With gain- and loss-of-function approaches, we demonstrated that C1GALT1 promoted GC cell proliferation, migration, and invasion. By employing lectin pull-down assay and mass spectrometry, integrin α5 was identified as a new downstream target of C1GALT1 in GC. C1GALT1 was able to modify O-linked glycosylation on integrin α5 and thereby modulate the activation of the PI3K/AKT pathway. Functional experiments indicated that integrin α5 inhibition could reverse C1GALT1-mediated tumor growth and metastasis both in vitro and in vivo. Moreover, transcription factor SP1 was found to bind to the C1GALT1 promoter region and activated its expression. Further investigation proved that miR-152 negatively regulated C1GALT1 expression by directly binding to its 3′ -UTR. Conclusions: Our findings uncover a novel mechanism for C1GALT1 in the regulation of GC progression. Thus, C1GALT1 may serve as a promising target for the diagnosis and treatment of GC.Keywords
Funding Information
- National Natural Science Foundation of China (81902494)
This publication has 36 references indexed in Scilit:
- C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian CancerInternational Journal of Gynecological Cancer, 2017
- Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1Molecular Cancer Research, 2017
- Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote MetastasisMolecular Cancer Research, 2017
- A Key Regulator of Cell Adhesion: Identification and Characterization of Important N -Glycosylation Sites on Integrin α 5 for Cell MigrationMolecular and Cellular Biology, 2017
- RETRACTED: Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric CancerMolecular Therapy, 2017
- Bioinformatics insight into glycosyltransferase gene expression in gastric cancer: POFUT1 is a potential biomarkerBiochemical and Biophysical Research Communications, 2017
- Glycosylation: a hallmark of cancer?Glycoconjugate Journal, 2016
- RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonizationCancer Letters, 2016
- Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancerOncogene, 2015
- C1GALT1 Enhances Proliferation of Hepatocellular Carcinoma Cells via Modulating MET Glycosylation and DimerizationCancer Research, 2013